Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 20/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7605473 | 0.93 | FKBP1A (0.55) | FKBP1A | |
| SCHEMBL7253232 | 0.83 | FKBP1A (0.88) | FKBP1A | |
| SCHEMBL8796618 | 0.80 | FKBP1A (0.96) | FKBP1A | |
| SCHEMBL7246458 | 0.75 | FKBP1A (0.71) | FKBP1A | |
| SCHEMBL7432524 | 0.75 | FKBP1A (0.62) | FKBP1A | |
| SCHEMBL5834555 | 0.73 | FKBP1A (1.00) | FKBP1A | |
| SCHEMBL7396367 | 0.73 | FKBP1A (1.00) | FKBP1A | |
| SCHEMBL7249394 | 0.73 | FKBP1A (0.89) | FKBP1A | |
| SCHEMBL7980344 | 0.72 | FKBP1A (0.69) | FKBP1A | |
| SCHEMBL7980342 | 0.72 | FKBP1A (0.69) | FKBP1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2002522485-A | — | — | 2002-07-23 | — | — | JP | claimed |
| EP-1109554-A2 | PIPECOLIC ACID DERIVATIVES FOR VISION AND MEMORY DISORDERS | GPI NIL Holdings, Inc. (US) | 2001-06-27 | — | — | EP | claimed |
| WO-2000009109-A2 | PIPECOLIC ACID DERIVATIVES FOR VISION AND MEMORY DISORDERS | GPI NIL HOLDINGS, INC. (US) | 2000-02-24 | — | — | WO | claimed |
| EP-1083874-B1 | Use of a compound for the preparation of a medicament for treating alopecia or promoting hair growth in an animal | GUILFORD PHARM INC (US) | 2004-01-02 | — | — | EP | disclosed |
| US-6395758-B1 | VISION DEFECTS | GPI NIL HOLDINGS, INC. | 2002-05-28 | — | — | US | disclosed |
| US-20020037924-A1 | Small molecule carbamate or urea hair growth compositions and uses | GPI NIL HOLDINGS, INC. (US) | 2002-03-28 | — | — | US | disclosed |
| US-6335348-B1 | ADMINISTERING PIPECOLIC ACID DERIVATIVE AS COGNITION ACTIVATOR AND TO TREAT EYE AND NERVOUS SYSTEM DISORDERS | GPI NIL HOLDINGS, INC. | 2002-01-01 | — | — | US | disclosed |
| US-6333340-B1 | SULFONAMIDES WITH OXO, ESTER OR AMIDE GROUPS FOR VISION DEFECTS AND COGNITION ACTIVATORS | GPI NIL HOLDINGS, INC. | 2001-12-25 | — | — | US | disclosed |
| US-20010036952-A1 | Small molecule pipecolic acid derivative hair growth compositions and uses | GPI NIL HOLDINGS, INC. (US) | 2001-11-01 | — | — | US | disclosed |
| US-20010029261-A1 | Small molecule sulfonamide hair growth compositions and uses | GUILFORD PHARMACEUTICALS INC. | 2001-10-11 | — | — | US | disclosed |
| EP-1104402-A1 | PIPECOLIC ACID DERIVATIVES AND THEIR USE FOR VISION AND MEMORY DISORDERS | GPI NIL Holdings, Inc. (US) | 2001-06-06 | — | — | EP | disclosed |
| US-6194440-B1 | Small molecule carbamate or urea hair growth compositions and uses | GPI NIL HOLDINGS, INC. | 2001-02-27 | — | — | US | disclosed |
| US-6191125-B1 | ALOPECIA THERAPY | GPI NIL HOLDINGS, INC. | 2001-02-20 | — | — | US | disclosed |
| US-6187796-B1 | ALOPECIA TREATMENT; IMMUNOPHILIN AFFINITY | GPI NIL HOLDINGS, INC. | 2001-02-13 | — | — | US | disclosed |
| WO-2000009484-A1 | PIPECOLIC ACID DERIVATIVES AND THEIR USE FOR VISION AND MEMORY DISORDERS | GPI NIL HOLDINGS, INC. (US) | 2000-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020037924-A1 | Small molecule carbamate or urea hair growth compositions and uses | SHH, CPS1, SLC14A1 | FKBP1A 1457/4885 |
| US-20010036952-A1 | Small molecule pipecolic acid derivative hair growth compositions and uses | PIP5K1C, PIP4K2C, PIP5K1A | FKBP1A 632/4885 |
| US-20010029261-A1 | Small molecule sulfonamide hair growth compositions and uses | PSAP, SHH, SPTSSB | FKBP1A 152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.